Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation.

Brain research bulletin - 30 Aug 2003

Wood Nigel I, Morton A Jennifer

Abstract excerpt

Expression of the Huntington's disease (HD) mutation in mice (R6/2 line) causes a progressive neurological phenotype that includes deterioration of motor function resembling that seen in HD. The current study sought to determine whether or not chronic treatment of R6/2 mice with lithium chloride...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimanic Agents
Share to Behavior, Animal
Share to Huntington Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lithium Chloride

Share to Motor Activity

Share to Psychomotor Performance

Share to Rotation

Share to Survival

Source

Identifiers

PMID: 12909280
DOI: 10.1016/s0361-9230(03)00141-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12909280-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation.PMID 12909280Read ↗

Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse.Semantic proximity Read ↗

Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic miceSemantic proximity Read ↗

Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.Semantic proximity Read ↗

Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's diseaseSemantic proximity Read ↗

A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.Semantic proximity Read ↗

XJB-5-131-mediated improvement in physiology and behaviour of the R6/2 mouse model of Huntington's disease is age- and sex- dependent.Semantic proximity Read ↗

Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.Semantic proximity Read ↗

Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice.Semantic proximity Read ↗

Environmental enrichment slows disease progression in R6/2 Huntington's disease mice.Semantic proximity Read ↗

Longitudinal analysis of the behavioural phenotype in R6/1 (C57BL/6J) Huntington's disease transgenic mice.Semantic proximity Read ↗

A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease.Semantic proximity Read ↗

A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.